Sabra Healthcare REIT Inc(SBRA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:15 PM ET (Korea 9/12 05:15)
Full metrics table
| Index | RUT | P/E | 78.89 | EPS (ttm) | 0.26 | Insider Own | 1.91% | Shs Outstand | 255.5M | Perf Week | -1.96% |
| Market Cap | 5.24B | Forward P/E | 26.8 | EPS next Y | 62.74% | Insider Trans | -4.22% | Shs Float | 250.6M | Perf Month | 1.63% |
| Enterprise Value | 7.66B | PEG | 3.11 | EPS next Q | 0.17 | Inst Own | 104.31% | Short Float | 7.73% | Perf Quarter | 10.98% |
| Income | 0.07B | P/S | 6.11 | EPS this Y | -26.49% | Inst Trans | -0.6% | Short Ratio | 6.61 | Perf Half Y | -1.25% |
| Sales | 0.86B | P/B | 1.91 | EPS next 5Y | 8.62% | ROA | 1.21% | Short Interest | 19.38M | Perf YTD | 8.34% |
| Book/sh | 10.77 | P/C | 21.99 | EPS past 3/5Y | - -0.96% | ROE | 2.4% | 52W High | -9.88% ($22.77) | Perf Year | 7.27% |
| Cash/sh | 0.93 | P/FCF | 13.86 | Sales past 3/5Y | 7.62% 5.48% | ROIC | 1.21% | 52W Low | 19.55% ($17.17) | Perf 3Y | 58.28% |
| Dividend Est. | $1.2 (5.85%) | EV/EBITDA | 20.65 | EPS Y/Y TTM | -65.5% | Gross Margin | 37.4% | Volatility(W/M) | 1.78% 1.82% | Perf 5Y | 35.05% |
| Dividend TTM | 1.2 | EV/Sales | 8.92 | Sales Y/Y TTM | 18.43% | Oper. Margin | 18.8% | ATR (14) | 0.44 | Perf 10Y | -9.3% |
| Dividend Ex-Date | 2026/8/14 | Quick Ratio | 2.05 | EPS Q/Q | -136.73% | Profit Margin | 7.62% | RSI (14) | 46.77 | Recom | 2.18 |
| Dividend Gr. 3/5Y | - -2.33% | Current Ratio | 2.05 | Sales Q/Q | 25.2% | SMA20 | -0.6% ($20.64) | Beta | 0.61 | Target Price | $22.8 |
| Payout | 188.56% | Debt/Eq | 0.96 | Earnings | 2026/8/3 | SMA50 | -0.81% ($20.69) | Rel Volume | 0.65 | Prev Close | $20.83 |
| Employees | 58 | LT Debt/Eq | 0.96 | EPS/Sales Surpr. | -158.45% 7.51% | SMA200 | 3.13% ($19.9) | Avg Volume(3M) | 2.93M | Price | $20.52 |
| IPO | 2002/4/2 | Option/Short | Yes/Yes | Trades | 15774 | Volume | 1,912,299 | Change | -1.49% |
Company
SBRA is a Real Estate sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A healthcare REIT that invests in US skilled nursing facilities, senior housing, and behavioral health facilities. It generates stable rental income by leasing nursing and medical facilities, and is expected to benefit from rising demand for healthcare and long-term care driven by population aging. It is a leading healthcare REIT known for a diversified tenant portfolio and consistent dividends.
Over the past 1 year, roughly in the middle
10% below its 1-year high.
SBRA makes money exceptionally well
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -26.5% this year.
Tap to view numbers
The price looks about right
Trading at 78.9 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to miss estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +58.3% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 5.85% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 104.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
BYRE 0.04%
SRET 0.04%
REIT 0.03%
JRE 0.03%
JPRE 0.02%It ranks #4 in the industry
Based on market cap of $5B.
SBRA $5B PER 78.9
WELL $170B PER -
VTR $47B PER 165.1
DOC $14B PER 58.0
FAQ
What kind of company is SBRA?
SBRA belongs to the Real Estate sector and operates in the REIT - Healthcare Facilities industry.
What is the market cap of SBRA?
The market cap of SBRA is approximately $5.2B, ranking 1,355 within its sector.
Does SBRA pay dividends?
SBRA has a dividend yield of approximately 5.85%, with an annual dividend of $1.20.
What is the P/E ratio of SBRA?
SBRA has a P/E ratio of approximately 78.9x, which can be used to assess its valuation relative to the Real Estate sector average.
What is the 52-week high and low for SBRA?
SBRA has recorded a 52-week high of $22.77 and a low of $17.17.
